PropertyValue
?:abstract
  • Infection with SARS-CoV-2 represents a great source of concern and a new threat for immunocompromised patients. Limited studies are available on COVID-19 in immunocompromised children. This case series aimed to evaluate the clinical and laboratory characteristics, management and outcomes of COVID-19 in five children immunocompromised due to different underlying conditions. All had mild symptoms or were asymptomatic at presentation. All had a benign course of illness. No changes or delays in their treatment regimens occurred, and none experienced a relapse of the original disease, developed severe COVID-19 or died. However, these cases showed a prolonged duration of virus shedding. This report suggests that immunocompromised paediatric patients may not be at a higher risk of developing severe COVID-19. However, further studies are required to elaborate on the pathogenesis of COVID-19 in this vulnerable group.
?:creator
?:journal
  • BMJ_case_reports
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Clinical course of COVID-19 among immunocompromised children: a clinical case series
?:type
?:who_covidence_id
  • #901288
?:year
  • 2020

Metadata

Anon_0  
expand all